Assyro AI

Orange Book product · Brand (NDA)

ARMONAIR RESPICLICK

FLUTICASONE PROPIONATE

Brand (NDA)NDA 208798DISCN TEVA PHARM

At a glance

Jul 09, 2021

Approved

Brand (NDA)

Application

Not listed

TE code

4

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jul 09, 2021

    5 yr ago

  2. Today

  3. Patent 10195375 expires

    Listed drug product patent expiration.

    Feb 14, 2031

    in 4 yr 9 mo

  4. Patent 10195375*PED expires

    Listed listed patent expiration.

    Aug 14, 2031

    in 5 yr 3 mo

  5. Patent 11969544 expires

    Listed drug product patent expiration.

    Aug 20, 2039

    in 13 yr 4 mo

  6. Patent 11969544*PED expires

    Listed listed patent expiration.

    Feb 20, 2040

    in 13 yr 10 mo

Pharmaceutical detail

Active ingredient

FLUTICASONE PROPIONATE

Strength

0.03MG/INH

Dosage form

POWDER

Route

INHALATION

TE code

Not listed

Application

NDA 208798

Product number

007

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (4)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
10195375Feb 14, 2031in 4 yr 9 mo
Product
10195375*PEDAug 14, 2031in 5 yr 3 mo
11969544Aug 20, 2039in 13 yr 4 mo
Product
11969544*PEDFeb 20, 2040in 13 yr 10 mo
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.